The effects of short-term fasting on tolerance to (neo) adjuvant chemotherapy in HER2-negative breast cancer patients: a randomized pilot study
暂无分享,去创建一个
H. Putter | H. Pijl | M. Welters | J. Nortier | M. Vreeswijk | J. V. D. van der Hoeven | J. Kroep | G. Gravesteijn | S. de Groot | J. Boei | D. Houtsma | A. Jochems | D. Houtsma
[1] T. Hickish,et al. Glucose Intolerance During Adjuvant Chemotherapy for Breast Cancer , 2016 .
[2] S. Groshen,et al. A Periodic Diet that Mimics Fasting Promotes Multi-System Regeneration, Enhanced Cognitive Performance, and Healthspan. , 2015, Cell metabolism.
[3] G. Giaccone,et al. A Phase I/II Trial of Belinostat in Combination with Cisplatin, Doxorubicin, and Cyclophosphamide in Thymic Epithelial Tumors: A Clinical and Translational Study , 2014, Clinical Cancer Research.
[4] H. Putter,et al. Addition of zoledronic acid to neoadjuvant chemotherapy does not enhance tumor response in patients with HER2-negative stage II/III breast cancer: the NEOZOTAC trial (BOOG 2010-01). , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.
[5] Mark P Mattson,et al. Fasting: molecular mechanisms and clinical applications. , 2014, Cell metabolism.
[6] F. Ghetti,et al. Kinetics of nuclear phosphorylation (γ-H2AX) in human lymphocytes treated in vitro with UVB, bleomycin and mitomycin C. , 2013, Mutagenesis.
[7] C. Du,et al. Correlation of dynamic changes in γ-H2AX expression in peripheral blood lymphocytes from head and neck cancer patients with radiation-induced oral mucositis , 2013, Radiation Oncology.
[8] H. Pijl,et al. Effects of prolonged fasting on AMPK signaling, gene expression, and mitochondrial respiratory chain content in skeletal muscle from lean and obese individuals. , 2013, American journal of physiology. Endocrinology and metabolism.
[9] P. Conti,et al. Fasting Enhances the Response of Glioma to Chemo- and Radiotherapy , 2012, PloS one.
[10] F. Rossi Fanelli,et al. Toxicity in chemotherapy--when less is more. , 2012, The New England journal of medicine.
[11] Maurice B. Bizino,et al. Food Cues Do Not Modulate the Neuroendocrine Response to a Prolonged Fast in Healthy Men , 2012, Neuroendocrinology.
[12] D. Sabatini,et al. mTOR Signaling in Growth Control and Disease , 2012, Cell.
[13] D. Hardie,et al. AMPK: a nutrient and energy sensor that maintains energy homeostasis , 2012, Nature Reviews Molecular Cell Biology.
[14] Vito Pistoia,et al. Fasting Cycles Retard Growth of Tumors and Sensitize a Range of Cancer Cell Types to Chemotherapy , 2012, Science Translational Medicine.
[15] C. Rübe,et al. The impact of individual in vivo repair of DNA double-strand breaks on oral mucositis in adjuvant radiotherapy of head-and-neck cancer. , 2011, International journal of radiation oncology, biology, physics.
[16] S. Vatner,et al. Caloric restriction reduces growth of mammary tumors and metastases. , 2011, Carcinogenesis.
[17] Changhan Lee,et al. Fasting vs dietary restriction in cellular protection and cancer treatment: from model organisms to patients , 2011, Oncogene.
[18] P. Bastani,et al. Quality of life and toxicity in breast cancer patients using adjuvant TAC (docetaxel, doxorubicin, cyclophosphamide), in comparison with FAC (doxorubicin, cyclophosphamide, 5-fluorouracil) , 2011, Archives of Gynecology and Obstetrics.
[19] T. Seyfried,et al. Influence of Caloric Restriction on Constitutive Expression of NF-κB in an Experimental Mouse Astrocytoma , 2011, PloS one.
[20] C. Parris,et al. Prolonged expression of the γ-H2AX DNA repair biomarker correlates with excess acute and chronic toxicity from radiotherapy treatment , 2011, International journal of cancer.
[21] D. Sabatini,et al. mTOR: from growth signal integration to cancer, diabetes and ageing , 2010, Nature Reviews Molecular Cell Biology.
[22] C. Rübe,et al. DNA repair alterations in children with pediatric malignancies: novel opportunities to identify patients at risk for high-grade toxicities. , 2010, International journal of radiation oncology, biology, physics.
[23] L. Partridge,et al. Extending Healthy Life Span—From Yeast to Humans , 2010, Science.
[24] T. Dorff,et al. Fasting and cancer treatment in humans: A case series report , 2009, Aging.
[25] Sterling C. Johnson,et al. Caloric Restriction Delays Disease Onset and Mortality in Rhesus Monkeys , 2009, Science.
[26] C. Redon,et al. γ-H2AX as a biomarker of DNA damage induced by ionizing radiation in human peripheral blood lymphocytes and artificial skin. , 2009, Advances in space research : the official journal of the Committee on Space Research.
[27] M. Löbrich,et al. DNA Double-Strand Break Repair of Blood Lymphocytes and Normal Tissues Analysed in a Preclinical Mouse Model: Implications for Radiosensitivity Testing , 2008, Clinical Cancer Research.
[28] L. Zitvogel,et al. Immunogenic cancer cell death: a key-lock paradigm. , 2008, Current opinion in immunology.
[29] S. Klein,et al. Long‐term effects of calorie or protein restriction on serum IGF‐1 and IGFBP‐3 concentration in humans , 2008, Aging cell.
[30] Changhan Lee,et al. Starvation-dependent differential stress resistance protects normal but not cancer cells against high-dose chemotherapy , 2008, Proceedings of the National Academy of Sciences.
[31] Linda J. Kuo,et al. γ-H2AX - A Novel Biomarker for DNA Double-strand Breaks , 2008 .
[32] W. Eiermann,et al. Pegfilgrastim +/- ciprofloxacin for primary prophylaxis with TAC (docetaxel/doxorubicin/cyclophosphamide) chemotherapy for breast cancer. Results from the GEPARTRIO study. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.
[33] L. Guarente,et al. Genetic links between diet and lifespan: shared mechanisms from yeast to humans , 2007, Nature Reviews Genetics.
[34] B. Bergman,et al. Effects of fasting on insulin action and glucose kinetics in lean and obese men and women. , 2007, American journal of physiology. Endocrinology and metabolism.
[35] P. Olive,et al. Phosphorylated histone H2AX in relation to cell survival in tumor cells and xenografts exposed to single and fractionated doses of X-rays. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[36] L. Tulman,et al. Symptom Clusters: Concept Analysis and Clinical Implications for Cancer Nursing , 2005, Cancer nursing.
[37] Matthias Egger,et al. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis , 2004, The Lancet.
[38] P. Olive,et al. Phosphorylation of histone H2AX as a measure of radiosensitivity. , 2004, International journal of radiation oncology, biology, physics.
[39] Stephen J Kron,et al. Histone H2AX Phosphorylation as a Predictor of Radiosensitivity and Target for Radiotherapy* , 2004, Journal of Biological Chemistry.
[40] Tim Byers,et al. Nutrition and Physical Activity During and After Cancer Treatment: An American Cancer Society Guide for Informed Choices , 2003, CA: a cancer journal for clinicians.
[41] Howard L McLeod,et al. Pharmacogenomics--drug disposition, drug targets, and side effects. , 2003, The New England journal of medicine.
[42] Taber MacCallum,et al. Calorie restriction in biosphere 2: alterations in physiologic, hematologic, hormonal, and biochemical parameters in humans restricted for a 2-year period. , 2002, The journals of gerontology. Series A, Biological sciences and medical sciences.
[43] S. Grottoli,et al. Effects of 36 hour fasting on GH/IGF-I axis and metabolic parameters in patients with simple obesity. Comparison with normal subjects and hypopituitary patients with severe GH deficiency , 2001, International Journal of Obesity.
[44] K. Matsumoto,et al. High-dose but not low-dose dexamethasone impairs glucose tolerance by inducing compensatory failure of pancreatic beta-cells in normal men. , 1996, The Journal of clinical endocrinology and metabolism.
[45] A. Turturro,et al. Age-Related Neoplasia in a Lifetime Study of Ad Libitum-Fed and Food-Restricted B6C3F1 Mice , 1995, Toxicologic pathology.
[46] J. Ketelslegers,et al. Nutritional regulation of the insulin-like growth factors. , 1994, Endocrine reviews.
[47] V. Grill,et al. Effects of dexamethasone on glucose-induced insulin and proinsulin release in low and high insulin responders. , 1990, Metabolism: clinical and experimental.
[48] R. Weindruch,et al. Dietary restriction in mice beginning at 1 year of age: effect on life-span and spontaneous cancer incidence. , 1982, Science.